Superluminal Medicines is a biotechnology company focused on advancing drug discovery and development through innovative technologies. It serves the healthcare industry by addressing unmet medical needs across various therapeutic areas.
Total Funding
$100M+
Total Rounds
3
First Raise
Sep 4, 2023
Latest Raise
Sep 3, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/3/2026 | |||
2 more funding rounds available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free